Early detection of male breast cancer: Warning signs, diagnosis and survival.

Male breast cancer: Symptoms, risk factors, diagnosis and treatment

Male breast cancer is an uncommon disease that develops when malignant cells grow in breast tissue, and the risk increases with age. Although breast cancer is diagnosed far more frequently in women, men can also develop the disease, and diagnosis may be delayed because routine breast cancer screening is not typically recommended for men at average risk. According to Kathryn Ruddy, MD, an oncologist at Mayo Clinic Comprehensive Cancer Center, recognising a breast lump, nipple discharge or unusual chest discomfort and seeking prompt medical assessment can help identify the disease before it advances.

Family history, inherited genetic mutations such as BRCA1 and BRCA2, Klinefelter syndrome, previous chest radiation and certain hormonal abnormalities can increase risk. Diagnosis generally involves clinical assessment, mammography or ultrasound, and a biopsy when findings are suspicious. Treatment depends on the cancer’s stage and may include surgery, radiation therapy, chemotherapy, endocrine therapy and targeted medicines.

Although Male breast cancer is often discovered at a later stage, outcomes depend substantially on the extent of disease at diagnosis, and prognosis can be comparable to that of women when cancers are detected at the same stage. This article examines the medical evidence, symptoms, risk factors, diagnostic procedures, staging, treatment options and emotional challenges associated with male breast cancer, while explaining why early assessment and participation in appropriate clinical trials matter.

Key Takeaways

Male breast cancer is uncommon, but persistent breast or nipple changes require prompt medical assessment.
Increasing age, family history and certain inherited genetic mutations can raise the risk.
Diagnosis involves clinical examination, breast imaging and biopsy when indicated.
Treatment is determined by cancer stage, tumour characteristics and the patient’s overall health.
Early detection and evidence-based treatment can improve the prospects for successful management.

Understanding male breast cancer

Male breast cancer develops when cells in breast tissue undergo abnormal changes and multiply uncontrollably. Although men generally have less breast tissue than women, they possess the ducts and other structures in which breast cancer can originate. The disease is rare, accounting for fewer than 1% of breast cancer cases in the United States, but its effects on patients and families can be substantial. The US National Cancer Institute estimated 2,800 new cases and 510 deaths from male breast cancer in 2025.

Age is an important factor. Male breast cancer is most frequently diagnosed in older men, often during their 60s or 70s, although younger men can also develop the disease. Because routine breast cancer screening is not generally recommended for men at average risk, many cases are first identified after a man notices a lump or another unusual physical change.

According to Mayo Clinic oncologist Kathryn Ruddy, MD, awareness of symptoms and timely medical assessment are essential to improving early detection. Men should understand that breast cancer is a genuine medical possibility, regardless of whether they have a family history or any recognised risk factors.

Symptoms of male breast cancer

A lump in the breast is the most common symptom of male breast cancer. It often develops close to the nipple because male breast tissue is concentrated in this area. The lump may feel firmer than the surrounding tissue and can have irregular edges. Although a lump may be painless, the absence of pain does not exclude cancer.

Other warning signs include nipple discharge, discomfort in the breast or chest, nipple retraction, changes in the skin covering the breast and unusual thickening of tissue. Skin changes may include dimpling, puckering, scaling, discolouration or ulceration. In some cases, swelling or a lump in the armpit may indicate that cancer has reached nearby lymph nodes.

Mayo Clinic explains that men frequently discover breast abnormalities themselves because routine screening is not typically recommended for the general male population.

“Since breast cancer screenings, such as mammograms and breast exams, aren’t typically recommended for men, they usually find a lump on their own,” Dr Ruddy says. “If men notice an unusual lump, experience nipple discharge, or chest or breast discomfort, they should seek medical attention promptly to determine the cause.”

These symptoms do not automatically mean cancer is present. Benign conditions, including gynaecomastia, which involves enlargement of male breast glandular tissue, can also cause breast lumps or tenderness. Cysts, infections and other conditions may produce similar changes. A clinical examination and appropriate diagnostic tests are necessary to establish the cause.

Men should seek prompt medical assessment for a new or persistent breast lump, unexplained nipple discharge or other unusual changes affecting the nipple, chest wall, armpit or nearby areas. Waiting for pain to develop is not a reliable approach to deciding whether a symptom requires investigation.

Risk factors for male breast cancer

Male breast cancer does not have one universal cause. It develops through changes in cellular DNA that interfere with normal growth and cell death. Certain inherited characteristics, medical conditions, treatments and hormonal changes can increase the likelihood of these changes occurring.

Age is one of the most important risk factors. The likelihood of developing breast cancer generally increases as men grow older, making persistent breast symptoms particularly important to investigate in later life. Nevertheless, age should never be used to dismiss a suspicious symptom in a younger man.

Family history is another significant consideration. A man with a close relative who has had breast cancer may have a higher risk, especially when several family members have been affected or when a relative was diagnosed at a young age. A history of breast cancer in male relatives deserves particular attention because it may indicate an inherited cancer predisposition.

Inherited mutations in the BRCA1 and BRCA2 genes are established risk factors. These genes normally help cells repair damaged DNA. Certain inherited variants impair this function and increase the likelihood of developing particular cancers.

BRCA2 variants are associated with a greater risk of male breast cancer than BRCA1 variants, although both can be relevant to personal and family health assessments. Genetic counselling and testing may be appropriate for men with a significant family history or a personal diagnosis of breast cancer.

Klinefelter syndrome is another recognised risk factor. This genetic condition usually occurs when a male is born with an additional X chromosome. It can affect testicular development, testosterone production and the balance between androgen and oestrogen hormones, contributing to a higher risk of breast cancer.

Previous radiation treatment directed at the chest wall can also increase risk. Some men receive chest radiation as part of treatment for conditions such as lymphoma. The effect on future cancer risk depends on factors including the radiation exposure and the individual’s medical history.

Certain testicular conditions and liver diseases may influence hormone levels and increase susceptibility. For example, liver cirrhosis can affect hormone metabolism, while some testicular disorders alter the balance of sex hormones. Oestrogen-containing medicines and particular forms of hormone therapy can also be relevant. Men taking prescribed medicines should discuss their individual risks with their healthcare professionals rather than stopping treatment independently.

Dr Ruddy summarises several of these factors:

“The risk for breast cancer in males increases with age and is more common in those who have a family history of breast cancer, especially male breast cancer,” Dr Ruddy adds. Some genetic mutations such as BRCA1 and BRCA2 also are known risk factors. Those with Klinefelter syndrome, a rare condition that occurs when men have an extra X chromosome, also are at higher risk.

She also notes the importance of previous treatment and hormonal conditions:

“Some medical treatments also can put men at greater risk, such as chest wall radiation, sometimes given to treat lymphoma. Some testicular and liver abnormalities that affect hormone levels also increase the risk for male breast cancer.”

Having one or more risk factors does not mean a man will develop cancer, and some men diagnosed with the disease have no obvious risk factors. Understanding personal and family medical history helps clinicians determine whether additional assessment or genetic counselling may be beneficial.

Types of male breast cancer

The most common form of male breast cancer is ductal carcinoma, which originates in the milk ducts. Both male and female breasts contain ducts, although male breast tissue generally has fewer developed glandular structures.

Ductal carcinoma in situ, commonly called DCIS, describes abnormal cells confined to the lining of the milk ducts without invasion into surrounding breast tissue. Invasive ductal carcinoma develops when malignant cells move beyond the duct into adjacent tissue. Invasive cancer may subsequently spread to nearby lymph nodes or distant organs.

Other forms of male breast cancer are much less common. These include Paget disease of the breast or nipple and inflammatory breast cancer. The specific type matters because the pathology findings help determine the most appropriate treatment.

Breast cancer cells are also assessed for hormone receptors, including oestrogen and progesterone receptors, and for human epidermal growth factor receptor 2, known as HER2. These biological characteristics can influence how a tumour grows and which medicines are likely to be effective. Most male breast cancers are hormone receptor-positive, making endocrine therapy an important treatment option for many patients.

Diagnosing male breast cancer

The diagnostic process begins with a medical history and clinical examination. A healthcare professional assesses the lump or other abnormality, examines the surrounding breast and chest tissue, and checks nearby lymph nodes. Information about symptom duration, previous medical treatment, family history and possible inherited risk factors can help guide further investigations.

Breast imaging is usually the next step when cancer is suspected. Depending on age and clinical findings, this may involve mammography, ultrasound or, in selected circumstances, magnetic resonance imaging. Mammography uses low-dose X-rays to produce detailed images of breast tissue, while ultrasound uses sound waves to distinguish different tissue structures and assess suspicious findings.

The precise imaging pathway depends on the patient’s age and presentation. The American College of Radiology recommends ultrasound as the initial imaging test for men younger than 25 when breast cancer is suspected, with mammography used if ultrasound findings are suspicious. For men aged 25 and older, diagnostic mammography is generally the initial examination, with ultrasound used when indicated.

If examination and imaging findings raise concern, a biopsy is needed to establish whether cancer is present. During this procedure, a clinician removes a sample of tissue, usually with a needle, for laboratory examination. A pathologist examines the sample under a microscope and may perform additional tests to identify the tumour type, grade and relevant biomarkers.

Once cancer is confirmed, further investigations may be required to determine its extent. These can include computed tomography, bone scans or positron emission tomography, depending on the clinical circumstances. Testing for oestrogen receptors, progesterone receptors and HER2 helps clinicians develop an individualised treatment plan.

A confirmed diagnosis does not by itself establish how far the cancer has spread. Imaging, pathology and other clinical findings must be considered together before staging and treatment decisions are made.

Staging male breast cancer

Breast cancer in men is staged using the same general system applied to women. Stages range from 0 to 4, describing the extent of the disease and whether malignant cells have spread beyond their original location.

Stage 0 refers to non-invasive disease, such as ductal carcinoma in situ, in which abnormal cells remain within the milk ducts. Stage 1 generally describes an early invasive cancer with limited spread. Stage 2 indicates a more extensive tumour or involvement of a limited number of nearby lymph nodes. Stage 3 describes locally advanced disease, which may involve more extensive regional lymph node involvement or surrounding structures. Stage 4 means the cancer has spread to distant organs or tissues, a process known as metastasis.

The precise stage is determined by factors such as tumour size, lymph node involvement, distant spread and relevant tumour characteristics. Staging provides essential information for estimating prognosis and selecting treatment.

Dr Ruddy explains the significance of early detection:

“Breast cancer in men is staged the same as in women, from 0 to 4. If detected at stage 0 before the cancer becomes invasive, nearly all patients will be cured,” Dr Ruddy explains. “However, if cancer is detected at stage 4, that means it has spread to other parts of the body, and it usually can be treated but not completely eliminated.”

These observations highlight the importance of identifying cancer before it spreads. Stage 0 disease has an excellent outlook, although treatment decisions still depend on the specific pathology and clinical circumstances. Stage 4 breast cancer is generally not considered curable with current standard treatments, but therapies can control the disease, relieve symptoms and help patients maintain quality of life.

Men are more likely than women to receive a breast cancer diagnosis at a later stage. This difference is associated partly with the absence of routine screening for most men and the possibility that symptoms may be overlooked or attributed to benign conditions.

Dr. Ruddy notes that female breast cancers are more often diagnosed at stages 0 and 1, while male breast cancers are more frequently found at stages 2, 3 and 4.

Nevertheless, a diagnosis of male breast cancer does not automatically mean a poor prognosis. The stage at diagnosis and the cancer’s biological characteristics are important determinants of treatment outcomes.

“When detected at the same stage, the prognosis for breast cancer in a male is no worse than that of breast cancer in a female,” Dr Ruddy says. “However, male breast cancers are more often diagnosed after they have already grown quite large in the breast, spread to lymph nodes under the arm or elsewhere in the body.”

These distinctions matter because survival statistics describe groups of patients rather than predicting an individual’s outcome. The most useful prognosis comes from a discussion with the treating oncology team, informed by the specific diagnosis, stage, biomarkers, general health and available treatments.

Sweet TnT 100 West Indian Recipes

Sweet TnT 100 West Indian Recipes serves as a comprehensive culinary guide to the Caribbean, featuring a diverse collection of home-cooked meals, street foods, and traditional drinks. This anniversary publication from Culturama Publishing Company highlights the authentic flavours of nations including Trinidad and Tobago, Jamaica, Barbados, and Guyana.

Treatment options for male breast cancer

Treatment for male breast cancer is guided by the cancer’s stage, tumour biology, the patient’s overall health and individual preferences. Surgery is commonly part of treatment for early-stage disease, while medicines become particularly important when cancer has spread to distant parts of the body.

Dr Ruddy explains the broad approach:

“If men are diagnosed with stage 0 to 3 cancer, surgery will be part of the treatment plan, while at stage 4, treatments will primarily use medications to fight the cancer throughout the body.”

For many men, mastectomy is the most common surgical procedure. It involves removing the breast tissue containing the cancer and may include removal of the nipple and surrounding areola. The surgeon may also assess nearby lymph nodes to determine whether cancer has spread.

Lumpectomy, also known as breast-conserving surgery, removes the cancer and a margin of surrounding tissue while preserving the remaining breast. It can be appropriate for selected men, depending on tumour size, location, the amount of available breast tissue and other clinical considerations. Radiation therapy may be recommended after breast-conserving surgery to reduce the risk of local recurrence.

Chemotherapy uses medicines to kill cancer cells or prevent them from multiplying. It may be recommended before surgery to reduce tumour size, after surgery to reduce the risk of recurrence, or in advanced disease to control cancer growth.

Endocrine therapy, also called hormone therapy, is particularly important because most male breast cancers depend on hormones for growth. Tamoxifen is commonly used to treat hormone receptor-positive disease. It works by blocking oestrogen receptors in breast cancer cells, reducing the hormone’s ability to stimulate their growth. Other endocrine treatments may be considered according to the disease characteristics and individual circumstances.

Radiation therapy uses targeted high-energy radiation to destroy cancer cells. It may be recommended after surgery when there is a significant risk of cancer remaining in the chest wall or nearby lymph nodes. The decision depends on factors such as tumour size, surgical findings and lymph node involvement.

Targeted therapies may be appropriate when laboratory testing identifies particular molecular characteristics, including HER2 positivity. These medicines act on specific pathways involved in cancer growth and can be combined with other treatments when indicated. The treatment plan should reflect the individual tumour rather than the patient’s sex alone.

Clinical trials and advances in male breast cancer research

Research into male breast cancer faces a significant challenge: the disease is uncommon, which makes it difficult to enrol large numbers of men in clinical trials. Consequently, many treatment recommendations have historically relied on evidence obtained from studies involving women with breast cancer.

Although many principles of treatment apply to both sexes, researchers continue to investigate whether particular medicines, combinations and treatment schedules offer the best balance of effectiveness and safety for men.

The ETHAN trial, described in the October 2026 Mayo Clinic report, is an example of research addressing this evidence gap. The Translational Breast Cancer Research Consortium is enrolling men with stage 1 to 3 breast cancer to study different anti-oestrogen and targeted treatment approaches before surgery.

The trial is designed to improve understanding of endocrine therapy in male breast cancer. Its findings may help clinicians determine how different treatment approaches affect tumour response and inform future care. The study should not be interpreted as proof that one treatment is superior before results are established.

Clinical trial participation can provide eligible patients with access to investigational approaches while helping researchers develop better evidence for future patients. Men interested in participating should discuss eligibility, potential benefits, risks and alternative treatments with their oncology team. Trial availability varies by location, diagnosis and recruitment status.

PMAX-4550 Multi Functional Smith Machine Training System

The Ritkeep Smith Cage Home Gym System – PMAX-4550 is an all-in-one home gym cage. This sturdy Smith Home Gym has an incredible amount of features suited for beginners and advanced users alike. The PMAX-4550 is an all-in-one Smith cage because it offers a ton of features, some only found in club gyms, such as a Smith Machine and cable crossovers. In addition, the multi-grip pull-up bar and detachable dip bars deliver body-weight workouts without the need for a separate power tower. This rack offers 10 adjustable heights, enabling users to optimize the height of cable crossover workouts to target chest muscles. Additionally, bar catch/safety catches enable additional exercises, such as presses and squats, and guarantee safe usage. For a more diversified workout routine, utilize the landmine attachment for exercises such as landmine squats and rows. The PMAX-4550 comes complete with a range of essential accessories, including a Lat Bar, Short Bar, T-bar, and D-Handles, allowing you to perform a wide array of exercises.

Emotional well-being and support after diagnosis

A male breast cancer diagnosis can carry emotional and social challenges alongside the physical demands of treatment. Because breast cancer is commonly associated with women, some men may feel embarrassed, isolated or reluctant to discuss their symptoms. These reactions can delay medical attention and make it more difficult to seek support after diagnosis.

Dr Ruddy highlights the importance of recognising these experiences:

“Because breast cancer is less common in men, some patients with male breast cancer can feel isolated or even ashamed of having a cancer typically associated with women,” Dr Ruddy says. “That’s why it’s important for men to talk with their healthcare team about how they’re feeling and, if possible, connect with other male breast cancer survivors in person or through online support groups.”

Open communication with healthcare professionals can help patients understand their diagnosis, prepare for treatment and discuss concerns about body image, relationships, work and recovery. Counselling, cancer support organisations and peer groups can provide additional assistance for patients and their families.

Family members may also need guidance on how to offer practical and emotional support. Accompanying a patient to appointments, helping organise treatment schedules and discussing concerns openly can make the experience easier to manage.

Emotional support should be considered part of comprehensive cancer care. Patients who experience persistent anxiety, depression or difficulty coping should tell their healthcare team, which can arrange appropriate psychological or supportive services.

Recognising warning signs and seeking early medical care

Improving outcomes for male breast cancer depends partly on reducing delays between the appearance of symptoms and medical assessment. Men should be familiar with the normal appearance and feel of their chest and seek advice when they notice persistent or unexplained changes.

Dr Ruddy emphasises that abnormalities may appear beyond the breast itself:

“To diagnose more men before their cancers grow large and spread, it’s important that they seek medical attention for changes in their chest wall, nipple, underarms or neck,” Dr Ruddy says.

A new lump, nipple discharge, nipple inversion, skin dimpling or unexplained swelling in the armpit warrants professional assessment. Men with a strong family history of breast cancer or a known inherited cancer-associated variant should discuss their individual risk and whether genetic counselling or specialist surveillance is appropriate.

There is no established prevention strategy that eliminates the risk of male breast cancer for everyone. However, understanding inherited risk, discussing relevant medical history and responding promptly to symptoms can help reduce avoidable delays in diagnosis.

Routine screening is not generally recommended for men at average risk, but this does not mean breast changes should be ignored. Men with known high-risk genetic variants may require an individualised surveillance plan based on specialist advice.

The importance of research and evidence-based care

Greater awareness of male breast cancer can help challenge misconceptions that the disease affects only women. Better recognition of symptoms may encourage men to seek assessment earlier, while continued research can improve treatment choices and long-term outcomes.

Dr Ruddy encourages eligible patients to consider contributing to clinical research:

“In addition, men who are diagnosed with breast cancer are encouraged to participate in clinical trials, when available, to help improve male breast cancer treatment,” she adds. “Detecting cancer early and optimizing evidence-based treatments will lead to more cures.”

Clinical trials are not suitable for every patient, and established treatments remain important components of care. Decisions should be made collaboratively with qualified healthcare professionals who can explain the evidence, expected benefits, potential adverse effects and alternatives.

Mayo Clinic is a non-profit organisation committed to innovation in clinical practice, education and research, and to providing compassionate care and reliable medical information. Its work contributes to the broader effort to improve cancer diagnosis, treatment and patient support.

Awareness can make a difference

Male breast cancer is rare, but it is a recognised disease that deserves prompt attention when symptoms appear. Increasing age, inherited genetic variants, family history, Klinefelter syndrome, previous chest radiation and certain hormonal conditions can increase risk, although cancer may develop in men without these factors.

A new breast lump, nipple discharge or unexplained changes in the chest should prompt medical assessment. Diagnostic imaging and biopsy can establish whether cancer is present, while staging and biomarker testing guide treatment decisions.

Surgery, endocrine therapy, chemotherapy, radiation and targeted medicines can all have a role, depending on the individual diagnosis. Although male breast cancer is often discovered at a later stage, outcomes depend on the extent and biology of the disease, and early-stage cancers can have an excellent prognosis.

Reducing stigma, recognising warning signs, improving access to appropriate care and expanding clinical research are important steps towards better outcomes for men affected by breast cancer.

Medical note: This article is for general information and does not replace an assessment by a qualified healthcare professional. Anyone experiencing suspicious breast or chest changes should seek medical advice promptly.

About Mayo Clinic:

Mayo Clinic is a nonprofit organisation committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.

Sources for further information